- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 2.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.01M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 818.14K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $121K |
| Capex | Q1 2026 · Mar 31, 2025 | $435K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.69M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.18M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $24.37M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $4.75M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $29.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $32.03M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.19M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.65M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.12M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.44M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $28.44M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $30.88M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $32.84M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $35.47M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.23 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$5.42 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.23 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$5.42 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.99M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.14M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.47M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.44M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.59M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.62M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.61M |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.17M |